Significance of comorbidity for the long-term course of opiate dependence

European Addiction Research

Volumn 11, Issue 1, 2005, Pages 15-21

  Verthein, Uwe ^a,b   Degkwitz, Peter ^a   Haasen, Christian ^a   Krausz, Michael ^a  

^a Centre for Interdisciplinary Addiction Research   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Comorbidity; Long term course; Opiate dependence

Indexed keywords

OPIATE;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; FOLLOW UP; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; MENTAL DISEASE; OPIATE ADDICTION; PATIENT; PRIORITY JOURNAL; PROGNOSIS; PSYCHIATRIC DIAGNOSIS;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MENTAL DISORDERS; MENTAL STATUS SCHEDULE; PROGNOSIS; QUALITY OF LIFE; SOCIAL ADJUSTMENT; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 11444259611     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081412     Document Type: Article

References (22)

1. Khantzian EJ: The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-1264.
2. Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD: The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend 2001;61:271-280.
3. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M: Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 2000;176:285-289.
4. Frei A, Rehm J: Die Prävalenz psychischer Komorbidität unter Opiatabhängigen. Psychiatr Prax 2002;29:258-262.
5. Soyka M, Aichmüller C, Bardeleben U, Beneke M, Glaser T, Hornung-Knobel S, Wegner U: Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: Results from an open clinical study. Eur Addict Res 2003;9:65-72.
6. Backmund M, Schütz C, Meyer K, Eichenlaub D, Soyka M: Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients - Frequency and correlates of use. Eur Addict Res 2003;9:45-50.
7. Haver B: Comorbid psychiatric disorders predict and influence treatment outcome in female alcoholics. Eur Addict Res 2003;9:39-44.
8. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518.
9. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
10. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC: Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313-321.
11. Landheim AS, Bakken K, Vaglum P: Gender differences in the prevalence of symptom disorders and personality disorders among polysubstance abusers and pure alcoholics. Eur Addict Res 2003;9:8-17.
12. Bucholz KK: Nosology and epidemiology of addictive disorders and their comorbidity. Psychiatr Clin North Am 1999;22:221-240.
13. Strain EC, Brooner RK, Bigelow GE: Clustering a multiple substance use and psychiatric diagnoses in opiate addicts. Drug Alcohol Depend 1991;27:127-134.
14. Limbeek J, Wouters L, Kaplan CD, Geerlings PJ, Alem V: Prevalence of psychopathology in drug addicted Dutch. J Subst Abuse Treat 1992;9:43-52.
15. Darke S, Swift W, Hall W: Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 1994;89:211-217.
16. Krausz M, Degkwitz P, Kühne A, Verthein U: Comorbidity of opiate dependence and mental disorders. Addict Behav 1998;23:767-783.
17. Augustin R, Kraus L: Changes in prevalence of problem opiate use in Germany between 1990 and 2000. Eur Addict Res 2004;10:61-67.
18. Rounsaville BJ, Tierney T, Crits-Christoph K, Weissman MM, Kleber HD: Predictors of outcome in treatment of opiate addicts: Evidence for the multidimensional nature of addicts problems. Compr Psychiatry. 1982;23:462-478.
19. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD: Prognostic significance of psychopathology in treated opiate addicts. Arch Gen Psychiatry 1986;43:739-745.
20. Musselman DL, Kell MJ: Prevalence and improvement in psychopathology in opioid-dependent patients participating in methadone maintenance. J Addict Dis 1995;14:67-82.
21. Verthein U, Degkwitz P, Krausz M: Psychische Störungen und Verlauf der Opiatabhängigkeit. Psychiatr Prax 2000;27:77-85.
22. Koeter MWJ, Hartgers C: European Addiction Severity Index EuropASI. Gast AG. Preliminary procedure for the computation of the EuropASI Composite Scores. Amsterdam, 1997.